Skip to content
HowShorted

ANAVEX LIFE SCIENCES CORP. short interest in 2025

In 2025, ANAVEX LIFE SCIENCES CORP.'s disclosed short interest ran from 27.58% of shares outstanding on 15 Jan 2025 to 21.99% on 31 Dec 2025, a change of -5.59 percentage points. The year's high was 33.46% on 14 Nov 2025 and its low 21.99% on 31 Dec 2025, averaging 28.69% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 42.03 days on 30 Apr 2025. Full history: ANAVEX LIFE SCIENCES CORP..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ANAVEX LIFE SCIENCES CORP. in 2025

2025 in figures

Start of year
27.58% (15 Jan 2025)
End of year
21.99% (31 Dec 2025)
Change
-5.59 pp
High
33.46% (14 Nov 2025)
Low
21.99% (31 Dec 2025)
Average
28.69%
Highest days to cover
42.03 (30 Apr 2025)
SEC filings marked
5

Every report in 2025

ANAVEX LIFE SCIENCES CORP. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 202527.58%9.80
31 Jan 202527.62%17.39
14 Feb 202528.54%23.2110-Q filed
28 Feb 202527.64%22.20
14 Mar 202528.35%25.20
31 Mar 202528.99%20.72
15 Apr 202528.31%17.98
30 Apr 202527.70%42.03
15 May 202528.23%28.9210-Q filed
30 May 202529.32%24.11
13 Jun 202529.53%35.10
30 Jun 202529.43%22.03
15 Jul 202529.45%25.30
31 Jul 202529.06%18.49
15 Aug 202529.53%26.6810-Q filed
29 Aug 202529.70%32.19
15 Sep 202528.92%21.10
30 Sep 202529.23%26.13
15 Oct 202530.99%15.54
31 Oct 202531.04%26.45
14 Nov 202533.46%6.27
28 Nov 202528.14%6.7510-K filed, results (8-K)
15 Dec 202525.79%9.08
31 Dec 202521.99%8.01

See also: ANAVEX LIFE SCIENCES CORP.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.